HIGHLIGHTS
- who: Kotaro Miyao et al. from the Postgraduate Institute of Medical Education and Research, India Jinan University, China have published the article: Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?, in the Journal: (JOURNAL)
- what: In this review article, the authors will mainly discuss PCNSL developed in immunocompetent patients and briefly review PCNSL in patients with HIV-1 infection. According to Abramson et_al, seven patients who enrolled in this study had secondary CNS lesions, and six of these patients were evaluable for CART19 efficacy.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.